Although it rejected Alimentation Couche-Tard’s enhanced offer of approximately $5.91 billion (CA$7.8 billion), Caltex nevertheless believes that the convenience store and service station operator is a “serious” and “trustworthy” contender.
For this reason, the Australian company decided to offer the Quebec multinational the opportunity to have access to nonpublic information so that it could make a higher bid.
Many other publications overlook breaking business headlines focused on investing. Born2Invest mobile app helps readers stay on top of the latest news and financial affairs of the world.
“We received feedback from shareholders and thought it was important to take a constructive approach,” explained Caltex Chief Financial Officer Matthew Halliday on Thursday, December 5, at a conference for investors and analysts.
However, the company has not received a response from Couche-Tard since the announcement of the offer rejection. If the transaction were to proceed, it would become the largest acquisition of the Quebec giant.
On Tuesday, December 3, Couche-Tard had indicated by email that they had “nothing to add on the subject at this time.” At midday on Thursday, December 5, the company did not answer the questions sent by The Canadian Press.
The Quebec giant, which wants to double its size within five years, made an initial offer of $21.89 (A$32) for each Caltex share last October, but it was rejected because its price was deemed inadequate. The latter had come back to the table by proposing $23.60 (A$34.50) for each share of Caltex, which operates a network of some 2000 service stations, in addition to owning a refinery and fuel distribution and transportation assets.
Caltex management briefly commented on Couche-Tard’s offensive, noting that profits are expected to decline this year, in addition to announcing the sale of 25 sites that sell fuel. It also had to defend its decision to allow the Laval company to have access to inside information – in exchange for a confidentiality agreement – when there is no firm offer on the table.
“It’s not to do a pre-check,” said Mr. Halliday. It’s more to offer a way to come back with a proposal that could generate more value for our shareholders.” At a price of $23.60 (A$34.50) per share, Couche-Tard’s proposal represents a premium of approximately 16% over the closing price of Caltex’s stock on November 25, prior to the announcement of the receipt of an offer to purchase.
Caltex has nearly 6630 employees. On the Sydney Stock Exchange on Thursday, December 5, it was trading on stock at $23.52 (A$34.38), slightly below the $23.60 (A$34.50) price proposed by Couche-Tard in its enhanced proposal.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in leDetroit, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Two French laboratories announced investments recently
The French laboratory Pierre Fabre announced an investment of $5.3 million (€4.5 million) to produce the active ingredients for binimetinib...
Rritual builds mass market appeal for functional mushroom adaptogens: case study in health marketing
Marketing a product in any niche is tricky, but marketing a product beyond its niche is folly. Or brilliance. The...
Italy has classified CBD as a narcotic: CBD oils are to disappear from stores
Italy has just classified CBD as a narcotic. The decree is a threat to the entire cannabis industry in Italy,...
Workinvoice to launch the invoice advance integrated in the management software
Workinvoice and Passepartout launched the invoice integrated in the management software. Invoice trading allows companies to assign outstanding trade receivables...
7 important Augmented and Virtual Reality trends for 2020
As one of the fastest-changing industries globally, AR and VR keep surprising us with fresh use cases and applications. In...
Featured6 days ago
B2B only: Spotcap sells credit business to Ferratum
Featured7 days ago
Domestic demand versus export demand: which is better?
Business6 days ago
Not all software IPOs are created equal
Business7 days ago
Stay safe and survive the second wave: The savvy investors guide to stock selection